Yahoo! Finance Search - Finance Home - Yahoo! - Help

Tuesday, September 16 2014 7:33am ET - U.S. Markets open in 1 hour and 57 minutes.
Industry Center - Drugs - Generic
Industry Center > Drugs - Generic > News
More On This Industry
· Summary
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drug Related Products
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
Drugs - Generic News
Latest News
Tuesday, Sep 16, 2014
·Mylan Commences Phase III Clinical Trials for its Generic Version of Advair Diskus® and Insulin Analog to Lantus®
PR Newswire - 3 minutes ago
·U.S. Index Futures Are Little Changed Before Fed Meeting
at Bloomberg - 1 hour, 22 minutes ago
·PRESS DIGEST- New York Times business news - Sept 16
Reuters - Tue 12:17 am ET
Monday, Sep 15, 2014
·GALECTIN SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Galectin Therapeutics Inc. - GALT
GlobeNewswire - Mon 10:00 pm ET
·Actavis Sued by New York Attorney General Over Namenda Switch
at Bloomberg - Mon 8:36 pm ET
·New York Files an Antitrust Suit Against the Maker of an Alzheimer’s Drug
at The New York Times - Mon 7:20 pm ET
·APNewsBreak: NY bid to halt Alzheimer's drug swap
AP - Mon 7:11 pm ET
·UCERIS® (budesonide) 2mg Rectal Foam for the Induction of Remission of Mild-to-Moderate Distal Ulcerative Colitis Granted Tentative Approval by FDA
Business Wire - Mon 5:31 pm ET
·Why Avanir Pharmaceuticals (AVNR) Stock Soared to a One-Year High Today
at - Mon 4:06 pm ET
·Parnell Pharmaceuticals Holdings Ltd Announces Fiscal Year 2014 Financial Results
GlobeNewswire - Mon 4:00 pm ET
·Avanir Pharma soars on agitation drug study
AP - Mon 2:50 pm ET
·Gilead Deal to Sell Sovaldi in Poor Countries Meets Criticism
at The Wall Street Journal Online - Mon 1:44 pm ET
·[video] Gilead Expands Access of Hepatitis C Drug in Developing Countries
at - Mon 1:38 pm ET
·US STOCKS-Wall St little changed but tech weighs on Nasdaq
Reuters - Mon 11:26 am ET
·Alzheimer’s Study Results Take Avanir Back Up to Multiyear Highs
- Mon 10:35 am ET
·Avanir's Over-Priced Cough Syrup Touted For Role in Alzheimer's Agitation
at - Mon 10:19 am ET
·Gilead to license generic version of Sovaldi
AP - Mon 10:05 am ET
·Targeted Medical Pharma, Inc. – "Welcome to the Targeted Medical Pharma Blog"
- Mon 9:25 am ET
·Gilead signs hepatitis C pact to cut drug cost for poor
Reuters - Mon 9:04 am ET
·Avanir Pharmaceuticals Announces Positive Phase II Trial Results for AVP-923 in Treatment of Agitation in Patients with Alzheimer's Disease
PR Newswire - Mon 8:30 am ET
More Latest News...
Sponsor Results
Professional Statistician
1-on-1 Collaboration for your Project, Research, or Dissertation
Paperless Reg Docs
Secure online portal for clinical study start-up.
M/A/R/C Research
Full-service marketing research solutions customized to your needs
(What's This?)

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Drugs - Generic Headlines
More Finance RSS Feeds

Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2014 Morningstar, Inc. All Rights Reserved. Company information © 2014 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2014, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?